Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Vicarious Surgical ( (RBOT) ) just unveiled an update.
On December 12, 2025, Vicarious Surgical Inc. entered into an At the Market Offering Agreement with H.C. Wainwright & Co., LLC to sell shares of its Class A common stock, subject to certain conditions. This agreement allows the company to manage the sale parameters and provides flexibility in raising capital. Additionally, on December 15, 2025, Vicarious Surgical announced its 2026 cash burn guidance, projecting a reduction to $35 million, reflecting a $10 million improvement from 2025. This improvement is attributed to cost management strategies, including headcount reductions and strategic outsourcing, which aim to support the company’s goal of achieving a design freeze on its surgical system by the end of 2026.
The most recent analyst rating on (RBOT) stock is a Hold with a $7.00 price target. To see the full list of analyst forecasts on Vicarious Surgical stock, see the RBOT Stock Forecast page.
Spark’s Take on RBOT Stock
According to Spark, TipRanks’ AI Analyst, RBOT is a Underperform.
Vicarious Surgical’s stock score reflects significant financial challenges as a pre-revenue company with high cash burn, offset by a moderately stable balance sheet. Technical analysis indicates bearish sentiment, compounded by valuation challenges due to negative earnings. While the earnings call showed strategic advancements, supply chain delays and NYSE compliance issues pose risks. Successful clinical trials and improved cash management will be critical for future performance.
To see Spark’s full report on RBOT stock, click here.
More about Vicarious Surgical
Vicarious Surgical Inc., founded in 2014 and headquartered in Waltham, Massachusetts, is a next-generation robotics technology company focused on transforming robotic surgery. The company develops proprietary human-like surgical robots aimed at increasing surgical efficiency, improving patient outcomes, and reducing healthcare costs. Vicarious Surgical is supported by notable investors including Bill Gates and Khosla Ventures.
Average Trading Volume: 115,636
Technical Sentiment Signal: Sell
Current Market Cap: $17.36M
For an in-depth examination of RBOT stock, go to TipRanks’ Overview page.